Ustekinumab in Crohn's disease: evidence to date and place in therapy
about
Insights on the use of biosimilars in the treatment of inflammatory bowel disease.Update on the Use of Biologic Therapy in Ulcerative Colitis.The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study.
P2860
Ustekinumab in Crohn's disease: evidence to date and place in therapy
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Ustekinumab in Crohn's disease: evidence to date and place in therapy
@ast
Ustekinumab in Crohn's disease: evidence to date and place in therapy
@en
Ustekinumab in Crohn's disease: evidence to date and place in therapy
@nl
type
label
Ustekinumab in Crohn's disease: evidence to date and place in therapy
@ast
Ustekinumab in Crohn's disease: evidence to date and place in therapy
@en
Ustekinumab in Crohn's disease: evidence to date and place in therapy
@nl
prefLabel
Ustekinumab in Crohn's disease: evidence to date and place in therapy
@ast
Ustekinumab in Crohn's disease: evidence to date and place in therapy
@en
Ustekinumab in Crohn's disease: evidence to date and place in therapy
@nl
P2860
P356
P1476
Ustekinumab in Crohn's disease: evidence to date and place in therapy
@en
P2093
P2860
P304
P356
10.1177/2040622316653306
P407
P50
P577
2016-07-06T00:00:00Z